Senator Maggie Hassan Blasts GSK for Discontinuing Common Children’s Asthma Inhaler to Dodge Price Cap

US Senator Maggie Hassan, D-New Hampshire, slammed GlaxoSmithKline (GSK) last week for discontinuing its popular asthma inhaler for children in an alleged attempt to “price-gouge families.”

As of January 1, the British drugmaker stopped making its Flovent (fluticasone propionate) inhaler and instead, is offering an authorized generic version through a different company. Flovent was one of the most commonly prescribed inhalers for young children with asthma. It is also among the only inhalers infants can use.